Innovenn operates as a leading pharmaceutical company located in Madison, Wisconsin, dedicated to advancing disease management through innovative research and patient care solutions. The company focuses on transforming data into significant health improvements, particularly for rare diseases. Innovenn offers a variety of services, including Software as a Medical Device (SaMD), medical device development, drug development consulting, and regulatory approval support.
Innovenn emphasizes its expertise in 510k submissions, de novo classifications, and premarket approvals while adhering to FDA design control guidelines. The team collaborates with clients to create innovative medical device designs that prioritize patient input, ensuring the highest quality and safety standards. The commitment to cost-saving solutions and effective disease management sets Innovenn apart in the pharmaceutical landscape.
With a mission to drive healthcare innovation, Innovenn has established itself as a trusted partner in the industry. The focus on rare diseases highlights the company’s dedication to addressing unmet medical needs. By combining advanced research methods with patient-centered approaches, Innovenn delivers impactful healthcare solutions that improve lives.
Innovenn provides comprehensive services in medical device and drug development, regulatory support, and patient care solutions. The company's commitment to innovation and quality ensures effective disease management. Connect with Innovenn in Madison, Wisconsin, to explore how their expertise can advance healthcare solutions.
